Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

TrialWire, a leader in clinical trial recruitment innovation, launched its groundbreaking AI Voice Screen service as part of ...

Commercial relevance was one of the main reasons for Adelong operation Flemington Limousin and Angus to enter the 2025 Beef ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.

Donald Trump's aides are fully supportive of Elon Musk's efforts to drastically cut government spending, but his decisions ...

For more than a decade, the Food and Drug Administration (FDA) has made diversity in clinical trials a focus, including by issuing guidance, ...

CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...

BIO CEO & Investor conference Format: "IPO Class of 2024 Panel" and one-on-one meetings Date: February 10, 2025 Location: New York, NY Registered conference attendees may schedule one-on-one meetings ...

The gender data gap refers to the systemic lack of data relevant to the experiences of women and girls. This is particularly ...

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

Annovis Bio has commenced the treatment of subjects in a Phase III clinical trial of buntanetap in treating early Alzheimer's ...